Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: US Securities and Exchange Commission (SEC)
Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...
Dave Bloom
-
2023/05/11
Company is developing UTULY for intranasal emergency epinephrine delivery.
Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating...
News Wire ~ 3rd Party Press Release
-
2019/09/27
Mylan agreed to pay $30 million to settle charges they overcharged Medicaid hundreds of millions of dollars for EpiPen.
Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million
Dave Bloom
-
2019/01/21
Windgap Medical is securing funding to continue development.
Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate
Dave Bloom
-
2019/01/16
The FDA has shelved consideration of the drug until funding is restored.
Department of Justice Investigating Mylan Regarding Trade Compliance for Certain Products
Dave Bloom
-
2018/05/15
Manufacturer of EpiPen complies with DOJ requests and warrant issued by a special prosecutor's office in Milan, Italy.
Food Allergen Detector Draws $20 Million in Venture Funding
Dave Bloom
-
2017/10/25
The device joins others intended for use as portable "point of consumption" testers.